Abstract:Chronic obstructive pulmonary disease (COPD) is a prevalent and debilitating respiratory disorder characterized by persistent airflow limitation and chronic inflammation. In recent years, the role of mitochondrial dysfunction in COPD pathogenesis has emerged as a focal point of investigation. This review endeavors to unravel the molecular nexus between mitochondrial dysfunction and COPD, delving into the intricate interplay of oxidative stress, bioenergetic impairment, mitochondrial genetics, and downstream cellular consequences. Oxidative stress, a consequence of mitochondrial dysfunction, is explored as a driving force behind inflammation, exacerbating the intricate cascade of events leading to COPD progression. Bioenergetic impairment sheds light on the systemic consequences of mitochondrial dysfunction, impacting cellular functions and contributing to the overall energy imbalance observed in COPD patients. This review navigates through the genetic landscape, elucidating the role of mitochondrial DNA mutations, variations, and haplogroups in COPD susceptibility and severity. Cellular consequences, including apoptosis, autophagy, and cellular senescence, are examined, providing insights into the intricate mechanisms by which mitochondrial dysfunction influences COPD pathology. Therapeutic implications, spanning antioxidant strategies, mitochondria-targeted compounds, and lifestyle modifications, are discussed in the context of translational research. Important future directions include identifying novel biomarkers, advancing mitochondria-targeted therapies, and embracing patient-centric approaches to redefine COPD management. This abstract provides a comprehensive overview of our review, offering a roadmap for understanding and addressing the molecular nexus between mitochondrial dysfunction and COPD, with potential implications for precision medicine and improved patient outcomes.

Mitochondria dysfunction in the pathogenesis of bronchial asthma

Multifaceted roles of mitochondria in asthma

Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics

Mitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma

Targeting the mitochondria in chronic respiratory diseases

The role of mitochondria in eosinophil function: implications for severe asthma pathogenesis

Mitochondrial Dysfunction in Inflammatory Responses and Cellular Senescence: Pathogenesis and Pharmacological Targets for Chronic Lung Diseases

Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases

Role of mitochondrial quality control in the pathogenesis of chronic obstructive pulmonary disease

Revisiting airway epithelial dysfunction and mechanisms in chronic obstructive pulmonary disease: the role of mitochondrial damage

Epithelial Mitochondrial Dysfunction in Lung Disease.

Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics

Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Unraveling the Molecular Nexus

Mitochondria protective and anti-apoptotic effects of peripheral benzodiazepine receptor and its ligands on the treatment of asthma in vitro and vivo

Mitochondrial metabolic reprogramming and chronic obstructive pulmonary disease

The Role of Mitochondrial Quality Control in Chronic Obstructive Pulmonary Disease

The pathophysiological role of mitochondrial oxidative stress in lung diseases

Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

Mitochondrial dysfunction induced by ambient fine particulate matter and potential mechanisms

Mitochondrial dysfunction and chronic lung disease

Mitochondrial dysfunction in the pathophysiology of renal diseases